Julie Milner

Julie Milner is a senior regulatory professional with extensive experience in international regulatory affairs, currently serving as VP Head of International Regulatory Affairs at Alnylam Pharmaceuticals since November 2021. Prior roles include Executive Director at Gilead Sciences, where Julie demonstrated expertise in managing high-performing teams and developing regulatory strategies for complex programs in fields such as oncology and infectious diseases. Julie Milner’s leadership is characterized by a commitment to empowering team members and fostering innovation within regulatory frameworks. With a track record of significant submissions and a strong foundation in various therapeutic areas, Julie holds a PhD in Microbiology from Nottingham Trent University and has held key positions at several leading pharmaceutical companies including Johnson & Johnson and GSK.